Andere Sprachen ProstaLund AB

Aktien

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 17:17:25 29.05.2024			% 5 Tage	% 1. Jan.
0.578 ^SEK	-0.34%		+2.48%	-64.54%

16.05.	ProstaLund AB (publ) meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
08.04.	ProstaLund AB (Publ) präsentiert zwei neue Studien mit Schelin Katheter	CI

ProstaLund AB - Interim report January-March 2024	16.05.
ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024	16.05.
ProstaLund hosted unannounced audit by TÜV SÜD	12.04.
Two new studies with ProstaLund´s Schelin Catheter® presented at EAU24 in Paris	08.04.
ProstaLund AB Presents Two New Studies with Schelin Catheter	08.04.
Schelin Catheter® - new study confirms efficiency and ease of use	27.02.
Year-end report – ProstaLund AB (publ)	16.02.
ProstaLund AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16.02.
New agreement - Esbjerg Hospital starts up with CoreTherm® treatments	12.12.
ProstaLund Signs an Agreement on Coretherm®? with the New Customer Sydvestjysk Sygehus	12.12.
Interim report - ProstaLund AB (publ)	07.11.
ProstaLund AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07.11.
Schelin Catheter® has had its premiere in France.	11.09.23
ProstaLund AB Announces its Schelin Catheter Premiere in France	11.09.23
Schelin Catheter® beneficial together with TURP	05.09.23
ProstaLund signs sales agent agreement for France	31.08.23
Prostalund Signs Sales Agent Agreement for France	31.08.23
Patent has been approved in China	15.08.23
ProstaLund AB Receives the Positive News on Utility Model Application for Their Product CoreFlow Soft Stent	15.08.23
ProstaLund AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25.07.23

Keine Ergebnisse zu dieser Suche